28 October 2022 · There is a risk of severe harm or death if PN is unintentionally infused too rapidly in babies. Healthcare professionals need to ensure safe practice.
15 December 2022 · Practical guidance to ensure opportunities to learn from local intelligence, including patient harm are translated into shared local and national learning
16 March 2021 · Medicines with RMM may not be suitable for inclusion within Patient Group Directions (PGDs). If used, the RMM must be stated within the PGD.
2 March 2021 · A number of COVID-19 vaccines are available, all with different handling and dosing requirements; sites need to plan to reduce the risk of errors
15 December 2022 · Understanding the role and responsibilities of the MSO in practice will assist organisations in delivering their medication safety agenda
6 March 2024 · Timely use of rasburicase for treatment of Tumour Lysis Syndrome is essential. Mitigation strategies can minimise harm associated with delayed therapy.
29 March 2023 · Discussion of key current medication safety challenges within healthcare with a focus on opioids. We aim to inspire partnership working across the system.